NCT02176200View on ClinicalTrials.gov

Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual® Respimat®, low inspiratory flow rate

DRUG

Berodual® Respimat®, medium inspiratory flow rate

DRUG

Berodual® Respimat®, high inspiratory flow rate

DRUG

Berodual® HFA-MDI, low inspiratory flow rate

DRUG

Berodual® HFA-MDI, medium inspiratory flow rate

DRUG

Berodual® HFA-MDI, high inspiratory flow rate

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY